The global automatic immunoassay analyzer market is anticipated to grow at a CAGR of 14.8% during the forecast period (2023-2030). The demand for automated immunoassay analyzers has seen a substantial rise, with increasing adoption in the biotechnology and pharmaceutical industries. This growth can be attributed to the escalating prevalence of chronic diseases such as oncology, cardiovascular conditions, and diabetes. Furthermore, there is a growing need to enhance healthcare facilities and promote modernization in the pharmaceutical sector, which is driving market expansion. Hence, market players are diligently working on introducing more advanced and effective systems to augment their market share and revenue. For instance, in July 2023, Siemens Healthineers announced the launch of the new Atellica CI Analyser for clinical chemistry and immunoassay testing. The launch comes after the analyser received approval from the US Food and Drug Administration (FDA). It is now available in several countries across the world. The Atellica CI Analyser enables both standalone labs and satellite labs within larger health networks to access the same reagents, consumables and intelligent software found in the company’s Atellica Solution.
Browse the full report description of “Automatic Immunoassay Analyzer Market Size, Share & Trends Analysis Report by Application (Infectious Diseases, Endocrinology, Drug Monitoring, Chronic Diseases, and Allergy Testing), and by Product (Immunofluorescence, Chemiluminescence, Enzyme Linked Fluorescent System, and Radioimmunoassay) Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/automatic-immunoassay-analyzer-market
In addition, the rise in demand of advanced diagnostic devices and increase in trends of automation and integration have led to the introduction of innovative products which are expected to offer significant growth opportunities. For instance, in August 2023, Fapon launched its latest chemiluminescence immunoassay system, Shine i8000/9000. The high-speed and fully automated analyzer has an ultra-high throughput of 900 tests/ hour and features an integrated and compact design with stable performance.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Application
o By Product
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes F. Hoffmann-La Roche Ltd., Abbott, BD, Beckman Coulter, Inc., Ortho Clinical Diagnostics, bioMérieux SA, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Automatic Immunoassay Analyzer Market Report Segment
By Application
By Product
Global Automatic Immunoassay Analyzer Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/automatic-immunoassay-analyzer-market